...
首页> 外文期刊>Diagnostic cytopathology >Recognizing breast ductal carcinoma in situ on fine-needle aspiration: A diagnostic dilemma
【24h】

Recognizing breast ductal carcinoma in situ on fine-needle aspiration: A diagnostic dilemma

机译:细针穿刺术原位认识乳腺导管癌:诊断难题

获取原文
获取原文并翻译 | 示例
           

摘要

In this study, we evaluated cytomorphologic features of different subgroups of ductal carcinoma in situ (DCIS); we compared seven cytologic features between DCIS and invasive ductal carcinoma (IDC) aspirates to determine whether diagnosis of stromal invasion can be made based on fine-needle aspiration (FNA) findings. There were 142 cases of DCIS and 1,978 cases of IDC enrolled in our study. FNA analysis revealed 80.3% sensitivity for DCIS and 94.7% sensitivity for IDC. High and intermediate grade DCIS exhibited marked nuclear abnormality (92.1% vs. 35.7%, 30.0%; P1 < 0.001, P2 < 0.001) and necrosis (69.7% vs. 0%, 10.0%; P1 < 0.001, P2 = 0.001) in a higher percentage of cases compared to low grade DCIS and intraductal/intracystic papillary carcinoma. The rates of background macrophages (71.3% for DCIS and 21.9% for IDC, P < 0.001) and extensive necrosis (54.0% for DCIS and 16.7% for IDC, P < 0.001) were significantly higher in DCIS compared to IDC. Lymphocytes were observed in conjunction with tumor cells more frequently in IDC (81.3%) compared to DCIS (36.8%, P < 0.001). Stromal fragments associated with tumor cells were only observed in invasive lesions (11.9% micro-invasive DCIS and 52.1% IDC). Tubular structures were found exclusively in IDC (11.5%). Cytologic criteria for diagnosis of high and low grade DCIS are different. The suspicion of DCIS is raised when background macrophages and extensive necrosis are observed. Stromal invasion is suggested by FNA if lymphocytes are entwined around tumor cells or if stromal fragments associated with tumor cells or tubular structures are observed.
机译:在这项研究中,我们评估了导管癌原位(DCIS)不同亚组的细胞形态学特征。我们比较了DCIS和浸润性导管癌(IDC)吸出物之间的七个细胞学特征,以确定是否可以基于细针抽吸(FNA)发现来诊断基质浸润。本研究共纳入142例DCIS病例和1,978例IDC病例。 FNA分析显示,DCIS的灵敏度为80.3%,IDC的灵敏度为94.7%。高中级DCIS表现出明显的核异常(92.1%vs. 35.7%,30.0%; P1 <0.001,P2 <0.001)和坏死(69.7%vs. 0%,10.0%; P1 <0.001,P2 = 0.001)。与低度DCIS和导管内/非原发性乳头状癌相比,病例的百分比更高。与IDC相比,DCIS的背景巨噬细胞(DCIS为71.3%,IDC为21.9%,P <0.001)和广泛坏死(DCIS为54.0%,IDC为16.7%,P <0.001)的比率显着更高。与DCIS(36.8%,P <0.001)相比,IDC(81.3%)中观察到淋巴细胞与肿瘤细胞结合的频率更高。仅在侵袭性病变中观察到与肿瘤细胞相关的基质基质片段(微侵袭性DCIS为11.9%,IDC为52.1%)。仅在IDC中发现了管状结构(11.5%)。诊断高低级DCIS的细胞学标准不同。当观察到背景巨噬细胞和广泛的坏死时,会引起对DCIS的怀疑。如果淋巴细胞缠绕在肿瘤细胞周围,或者如果观察到与肿瘤细胞或肾小管结构相关的基质片段,则FNA提示基质侵袭。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号